Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate in Exudative AMD
NCT00346957Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 1999
- Primary completion
- Apr 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of anecortave in exudative age-related macular degeneration, sponsored by Alcon Inc.. Started Apr 1999; status: completed.
02
Drugs
anecortave
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT00346957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346957.